ANIKA THERAPEUTICS, INC. DEF 14A

Company

Anika Therapeutics, Inc.

Filed

April 23, 2013

Period of Report

June 18, 2013

Accession Number

0001157523-13-001914

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →